Nodular regenerative hyperplasia: A new serious antiretroviral drugs side effect? [6]

AIDS

Volumn 21, Issue 11, 2007, Pages 1498-1499

  Sandrine, Pierre Francois ^a   Sylvie, Abel ^a   André, Edouard ^a   Abdoulaye, Diedhiou ^a   Bernard, Liautaud ^a   André, Cabie ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; DIDANOSINE; EMTRICITABINE; LOPINAVIR; NEVIRAPINE; TENOFOVIR; ZIDOVUDINE;

CYTOLYTIC HEPATITIS; DRUG WITHDRAWAL; HEPATOMEGALY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LIVER BIOPSY; LIVER HYPERPLASIA; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; SPLENOMEGALY;

ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DIDANOSINE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; HYPERPLASIA; LIVER; LIVER DISEASES; LIVER REGENERATION; MIDDLE AGED; NEVIRAPINE; ZIDOVUDINE;

EID: 34250799803     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328235a54c     Document Type: Letter

References (1)

1. Mallet V, Blanchard P, Verkarre V, Vallet-Pichard A, Fontaine H, Lascoux-Combe C, Pol S. Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients. AIDS 2007; 21:187-192.